← Back to Search

Mobile Telehealth for Alzheimer's Disease (I-CARE 2 Trial)

N/A

Recruiting

Led By Richard J Holden, PhD

Research Sponsored by Indiana University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

I-CARE 2 Trial Summary

This trial will evaluate if using the mobile app Brain CareNotes reduces caregiver burden & BPSD symptoms for patients with dementia & their caregivers.

Who is the study for?

This trial is for adults over 18 who are the main unpaid caregivers for someone with Alzheimer's or a related dementia. The caregiver must be able to read English and care for someone who lives in the community and sees their doctor regularly.Check my eligibility

What is being tested?

The study tests Brain CareNotes, a mobile app designed to help caregivers manage the stress of caring for someone with dementia. Participants will either use this app or an education-only app as a control, with reminders to use it over a year.See study design

What are the potential side effects?

Since this trial involves using mobile apps, there are no direct medical side effects. However, participants may experience increased stress or emotional discomfort if they find the apps unhelpful or challenging to use.

I-CARE 2 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Caregiver Burden

Patient BPSD

Secondary outcome measures

Caregiver Acute Care Utilization

Caregiver Depressive Symptoms

Patient Acute Care Utilization

Other outcome measures

App Use

Behavioral Intention Questionnaire

Caregiver Self-efficacy

+2 more

I-CARE 2 Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Brain CareNotes AppExperimental Treatment1 Intervention

Group II: Attention Control AppActive Control1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Regenstrief Institute, Inc.OTHER

26 Previous Clinical Trials

98,317 Total Patients Enrolled

2 Trials studying Caregiver Burden

80 Patients Enrolled for Caregiver Burden

National Institute on Aging (NIA)NIH

1,675 Previous Clinical Trials

28,020,725 Total Patients Enrolled

24 Trials studying Caregiver Burden

2,291 Patients Enrolled for Caregiver Burden

Indiana UniversityLead Sponsor

980 Previous Clinical Trials

981,602 Total Patients Enrolled

7 Trials studying Caregiver Burden

3,446 Patients Enrolled for Caregiver Burden

Media Library

Brain CareNotes Clinical Trial Eligibility Overview. Trial Name: NCT05733520 — N/A

Caregiver Burden Research Study Groups: Attention Control App, Brain CareNotes App

Caregiver Burden Clinical Trial 2023: Brain CareNotes Highlights & Side Effects. Trial Name: NCT05733520 — N/A

Brain CareNotes 2023 Treatment Timeline for Medical Study. Trial Name: NCT05733520 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment for this trial still available?

"This medical experiment, which was initially shared on the 1st of June 2023 and has recently been updated (May 18th 2023), is presently seeking participants."

Answered by AI

What is the scope of subjects participating in this investigation?

"Affirmative, the information hosted on clinicaltrials.gov demonstrates that this medical trial is still recruiting participants. It was first posted on June 1st 2023 and recently updated on May 18th 2023 and is looking for 160 people to enrol from two distinct sites."

Answered by AI